↓ Skip to main content

American Association for Cancer Research

Mastermind Like Transcriptional Coactivator 3 (MAML3) Drives Neuroendocrine Tumor Progression

Overview of attention for article published in Molecular Cancer Research, May 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (79th percentile)
  • Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

twitter
12 X users

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
17 Mendeley
Title
Mastermind Like Transcriptional Coactivator 3 (MAML3) Drives Neuroendocrine Tumor Progression
Published in
Molecular Cancer Research, May 2021
DOI 10.1158/1541-7786.mcr-20-0992
Pubmed ID
Authors

Nathaniel Alzofon, Katrina Koc, Kristin Panwell, Nikita Pozdeyev, Carrie B Marshall, Maria Albuja-Cruz, Christopher D Raeburn, Katherine L Nathanson, Debbie L Cohen, Margaret E Wierman, Katja Kiseljak-Vassiliades, Lauren Fishbein

X Demographics

X Demographics

The data shown below were collected from the profiles of 12 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 17 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 17 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 3 18%
Researcher 3 18%
Student > Ph. D. Student 2 12%
Student > Doctoral Student 2 12%
Student > Bachelor 1 6%
Other 1 6%
Unknown 5 29%
Readers by discipline Count As %
Medicine and Dentistry 5 29%
Biochemistry, Genetics and Molecular Biology 2 12%
Agricultural and Biological Sciences 2 12%
Nursing and Health Professions 1 6%
Mathematics 1 6%
Other 1 6%
Unknown 5 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 September 2021.
All research outputs
#3,819,947
of 23,308,124 outputs
Outputs from Molecular Cancer Research
#244
of 1,904 outputs
Outputs of similar age
#91,210
of 440,904 outputs
Outputs of similar age from Molecular Cancer Research
#8
of 35 outputs
Altmetric has tracked 23,308,124 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,904 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.1. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 440,904 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 79% of its contemporaries.
We're also able to compare this research output to 35 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.